Home Drug Codes J Codes J1325 · EPOPROSTENOL SODIUM
Updated July 1st, 2026

EPOPROSTENOL SODIUM J Code: J1325

Injection, epoprostenol, 0.5 mg

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for J1325, effective October 1, 2026: $17.247 per HCPCS billing unit, up 1.9% from $16.918. From CMS's final file.

?
Medicare Payment Limit ?
$16.918
/ HCPCS billing unit · Q3 2026
APC Payment Limit ?
Not published
CMS publishes none for Q3 2026
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
8
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, epoprostenol, 0.5 mg
HCPCS Added Date January 1, 1998
Manufacturer Multiple Manufacturers
Route of Administration Intravenous
Generic Status Multi-Source; Generic
Dosage Form Injection, Powder, Lyophilized, For Solution

About EPOPROSTENOL SODIUM

Epoprostenol Sodium is a medication aligned to the HCPCS J Code: J1325 for billing, pricing, and reimbursement purposes in the United States. Classified under Cardiology, it is administered via the intravenous route and manufactured by multiple companies.

According to CMS Drug Use Information: This medication is used to treat high blood pressure in the lungs (pulmonary arterial hypertension). It helps to increase your ability to exercise and improve symptoms such as shortness of breath and tiredness. It works by relaxing and widening the blood vessels (arteries) in the lungs and other parts of the body so that blood can flow more easily. This medication belongs to a class of drugs known as vasodilators.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. Showing 5 of 8 NDCs — log in for the full crosswalk.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
00173-0517-00 Flolan GlaxoSmithKline LLC 1 0.5 MG
00173-0519-00 Flolan GlaxoSmithKline LLC 3 1.5 MG
62756-0059-40 epoprostenol Sun Pharmaceutical Industries, Inc. 1 0.5 MG / 10 ML
66215-0402-01 Veletri Actelion Pharmaceuticals US, Inc. 3 1.5 MG / 10 ML
67457-0587-10 Epoprostenol Mylan Institutional LLC 1 0.5 MG / 10 ML
•••••-••••-•• Log in to view EPOPROSTENOL SODIUM
EPOPROSTENOL SODIUM
EPOPROSTENOL SODIUM
Login to view 3 more NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

EPOPROSTENOL SODIUM Pricing & Reimbursement

J1325 Private Payer Reimbursement
$15.82 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q3 2026

EPOPROSTENOL SODIUM CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)
Not on the CMS JW / JZ list

CMS does not include Epoprostenol Sodium (J1325) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J1325. Wastage billing guide →

EPOPROSTENOL SODIUM Medically Unlikely Edits (MUE)

The most billing units of J1325 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 0.5 mg. The limit is different in the office and the hospital. Use the one for your setting.

Practitioner Office
1 unit / day
= 0.5 mg per day
Hospital Outpatient
18 units / day
= 9 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg Enter a dose to see how many billing units it is and whether it is under the limit.

EPOPROSTENOL SODIUM Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Pulmonary Arterial Hypertension (PAH)
Drug Class
Prostacycline Vasodilator [EPC]Prostaglandins I [CS]Vasodilation [PE]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Epoprostenol Sodium billing and coding guide?
We have not yet identified a manufacturer source of Epoprostenol Sodium billing and coding information.
Are there any available Epoprostenol Sodium patient assistance programs?
Our team did not identify a source for Epoprostenol Sodium patient assistance information. Please reach out to our team if you feel that this is a mistake.
Where can I find Epoprostenol Sodium prescribing information?
EPOPROSTENOL SODIUM prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date. Visit Here →
Where can I find Epoprostenol Sodium side effect information?
Our team has not yet identified a source of side effects information for EPOPROSTENOL SODIUM. Please check back in a few weeks.
Does billing EPOPROSTENOL SODIUM require JZ/JW wastage modifiers?
CMS does not include EPOPROSTENOL SODIUM (J1325) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J1325. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.